UnitedHealth Says It’s Swapping Out Humira On Some Preferred-Drug Lists
The insurance giant signaled that in 2025 it will remove AbbVie's blockbuster arthritis drug from some reimbursement lists and promote cheaper biosimilar alternatives. Among other pharma news, Novo Nordisk's old weight loss drug Saxenda is found safe and effective for kids.